RankAlpha logo
Back to Rankings

CBUS

CibusD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CBUS vs peer average
46/100
CBUS vs. peer average (D vs. D)
Grade spread
B 2 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

INO is the first available peer comparator.

Loose same-sector and similar-market-cap comparator only; Inovio is a therapeutic biotech, so read-through to Cibus' agricultural gene-editing platform is limited mainly to small-cap funding volatility.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerINOInovio
CBUS
Cibus
INO
Inovio
Grade
D
D
Momentum
100
40
Value
41
41
Sentiment
18
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs INO

CBUS / INO
Grade Position
In line
CBUS vs. peer average (D vs. D)
46/100
Momentum
100
CBUS
Value
41
CBUS
Sentiment
18
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CBUS
1
INO
INO
D
40/100
Even
2
AGEN
AGEN
D
40/100
Even
3
MGNX
MGNX
C
60/100
-1
4
PYXS
Pyxis Oncology Inc Common
D
40/100
Even
5
HURA
TuHURA Biosciences Inc Common
B
80/100
-2
INO is the first peer returned for this comparison set.